These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Strategies for human papillomavirus therapeutic vaccines and other therapies based on the E6 and E7 oncogenes. Govan VA Ann N Y Acad Sci; 2005 Nov; 1056():328-43. PubMed ID: 16387699 [TBL] [Abstract][Full Text] [Related]
44. [Detection and molecular typing of human papillomaviruses: prevalence of cervical infection in the Tunisian central region]. Hassen E; Remadi S; Chouchane L Tunis Med; 1999 Oct; 77(10):497-502. PubMed ID: 10670281 [TBL] [Abstract][Full Text] [Related]
45. Epidemiology of mucosal human papillomavirus infection and associated diseases. Trottier H; Burchell AN Public Health Genomics; 2009; 12(5-6):291-307. PubMed ID: 19684442 [TBL] [Abstract][Full Text] [Related]
46. [What clinicians should know about human papilloma virus vaccines]. Sanclemente G Gac Med Mex; 2003; 139(2):173-83. PubMed ID: 12754956 [TBL] [Abstract][Full Text] [Related]
47. Global burden of human papillomavirus and related diseases. Forman D; de Martel C; Lacey CJ; Soerjomataram I; Lortet-Tieulent J; Bruni L; Vignat J; Ferlay J; Bray F; Plummer M; Franceschi S Vaccine; 2012 Nov; 30 Suppl 5():F12-23. PubMed ID: 23199955 [TBL] [Abstract][Full Text] [Related]
48. Epidemiology, clinical manifestations, and recent advances in vaccination against human papillomavirus. Broomall EM; Reynolds SM; Jacobson RM Postgrad Med; 2010 Mar; 122(2):121-9. PubMed ID: 20203463 [TBL] [Abstract][Full Text] [Related]
49. Prevention of human papilloma virus-induced preneoplasia and cancer by prophylactic HPV vaccines. Hampl M Minerva Med; 2007 Apr; 98(2):121-30. PubMed ID: 17519854 [TBL] [Abstract][Full Text] [Related]
50. Pathology and epidemiology of HPV infection in females. Stanley M Gynecol Oncol; 2010 May; 117(2 Suppl):S5-10. PubMed ID: 20304221 [TBL] [Abstract][Full Text] [Related]
51. The epidemiology of genital human papillomavirus infection. Trottier H; Franco EL Vaccine; 2006 Mar; 24 Suppl 1():S1-15. PubMed ID: 16406226 [TBL] [Abstract][Full Text] [Related]
52. HPV vaccines to prevent cervical cancer and genital warts: an update. Dochez C; Bogers JJ; Verhelst R; Rees H Vaccine; 2014 Mar; 32(14):1595-601. PubMed ID: 24606637 [TBL] [Abstract][Full Text] [Related]
53. The distribution of sexually-transmitted Human Papillomaviruses in HIV positive and negative patients in Zambia, Africa. Ng'andwe C; Lowe JJ; Richards PJ; Hause L; Wood C; Angeletti PC BMC Infect Dis; 2007 Jul; 7():77. PubMed ID: 17634108 [TBL] [Abstract][Full Text] [Related]
54. HPV infection in women: psychosexual impact of genital warts and intraepithelial lesions. Graziottin A; Serafini A J Sex Med; 2009 Mar; 6(3):633-45. PubMed ID: 19170869 [TBL] [Abstract][Full Text] [Related]
55. Papillomavirus and treatment. Snoeck R Antiviral Res; 2006 Sep; 71(2-3):181-91. PubMed ID: 16831473 [TBL] [Abstract][Full Text] [Related]
56. Pathogenesis of human papillomaviruses in differentiating epithelia. Longworth MS; Laimins LA Microbiol Mol Biol Rev; 2004 Jun; 68(2):362-72. PubMed ID: 15187189 [TBL] [Abstract][Full Text] [Related]
57. Vaccines for preventing HPV-related anogenital infection and neoplasia. Ferris DG J Am Osteopath Assoc; 2006 Mar; 106(3 Suppl 1):S9-13. PubMed ID: 16729555 [TBL] [Abstract][Full Text] [Related]
58. Genome variation of human papillomavirus types: phylogenetic and medical implications. Bernard HU; Calleja-Macias IE; Dunn ST Int J Cancer; 2006 Mar; 118(5):1071-6. PubMed ID: 16331617 [TBL] [Abstract][Full Text] [Related]
59. Cutaneous manifestations of human papillomaviruses: a review. Cardoso JC; Calonje E Acta Dermatovenerol Alp Pannonica Adriat; 2011 Sep; 20(3):145-54. PubMed ID: 22131115 [TBL] [Abstract][Full Text] [Related]